Anixa Biosciences (ANIX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Sep11

Anixa Biosciences released FY2025 9 Months earnings on September 10, 2025 (EST) with actual revenue of USD 0 and EPS of USD -0.255

03:00

Anixa Biosciences released FY2025 Q3 earnings on September 10, 2025 (EST), with actual EPS of USD -0.0695 (forecasted EPS USD -0.0866)

03:00

Jul15

Anixa Biosciences CEO Buys Company Stock

08:43

Jun23

Anixa Biosciences Launches Fourth Phase Clinical Trial for Recurrent Ovarian Cancer CAR-T Treatment

12:01

Jun20

Anixa Announces Investor Webcast on June 26

11:52

Jun9

Anixa to Present Ovarian Cancer CAR-T Therapy Clinical Trial Results

12:01

Schedules & Filings

Schedules

Filings

Sep10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -2.258 M, EPS -0.0695

May28

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -2.79 M, EPS -0.0866

Mar11

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -3.184 M, EPS -0.0988

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More